ORIC Pharmaceuticals Statistics Share Statistics ORIC Pharmaceuticals has 97.12M
shares outstanding. The number of shares has increased by 37.63%
in one year.
Shares Outstanding 97.12M Shares Change (YoY) 37.63% Shares Change (QoQ) 13.96% Owned by Institutions (%) 99.99% Shares Floating 45.7M Failed to Deliver (FTD) Shares 1,020 FTD / Avg. Volume 0.09%
Short Selling Information The latest short interest is 9.53M, so 9.81% of the outstanding
shares have been sold short.
Short Interest 9.53M Short % of Shares Out 9.81% Short % of Float 9.94% Short Ratio (days to cover) 8.77
Valuation Ratios The PE ratio is -4.4 and the forward
PE ratio is -6.66.
ORIC Pharmaceuticals's PEG ratio is
0.66.
PE Ratio -4.4 Forward PE -6.66 PS Ratio 0 Forward PS 136.7 PB Ratio 2.31 P/FCF Ratio -4.94 PEG Ratio 0.66
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ORIC Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.56,
with a Debt / Equity ratio of 0.04.
Current Ratio 10.56 Quick Ratio 10.56 Debt / Equity 0.04 Debt / EBITDA -0.07 Debt / FCF -0.08 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.05M Employee Count 122 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 20.29% in the
last 52 weeks. The beta is 1.68, so ORIC Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.68 52-Week Price Change 20.29% 50-Day Moving Average 10.42 200-Day Moving Average 8.69 Relative Strength Index (RSI) 59.05 Average Volume (20 Days) 1,121,534
Income Statement
Revenue n/a Gross Profit -1.11M Operating Income -142.9M Net Income -127.85M EBITDA -126.74M EBIT -127.85M Earnings Per Share (EPS) -1.83
Full Income Statement Balance Sheet The company has 59.41M in cash and 9.36M in
debt, giving a net cash position of 50.05M.
Cash & Cash Equivalents 59.41M Total Debt 9.36M Net Cash 50.05M Retained Earnings -562.77M Total Assets 346.86M Working Capital 273.07M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -112.66M
and capital expenditures -1.19M, giving a free cash flow of -113.85M.
Operating Cash Flow -112.66M Capital Expenditures -1.19M Free Cash Flow -113.85M FCF Per Share -1.63
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
